Quantitative analysis for Genelux Corporation (GNLX) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Sell (44.0) (grade D). 25 signals analyzed (21 differentiated alt-data).
GNLX stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $2.56 | $2.50 | $2.53 |
| 2026-05-08 | $3.20 | $2.83 | $3.11 |
| 2026-05-20 | $2.93 | $2.78 | $2.93 |
| 2026-06-02 | $3.03 | $2.91 | $2.95 |
| 2026-06-12 | $3.03 | $2.85 | $2.96 |
| 2026-06-25 | $2.97 | $2.84 | $2.90 |
| 2026-07-08 | $3.01 | $2.86 | $2.96 |
| 2026-07-20 | $2.97 | $2.78 | $2.93 |
| 2026-07-30 | $3.08 | $2.83 | $3.05 |
| 2026-08-12 | $2.73 | $2.54 | $2.70 |
| 2026-08-24 | $2.77 | $2.57 | $2.72 |
| 2026-09-03 | $2.58 | $2.46 | $2.52 |
How Genelux Corporation stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| NAKA | Nakamoto Inc. | $110M | — |
| OWLT | Owlet, Inc. | $108M | — |
| ALXO | ALX Oncology Holdings Inc. | $108M | 52.0 |
| CNTN | Canton Strategic Holdings Inc | $114M | — |
View all Health Care stocks by valuation and signals →
Genelux Corporation (GNLX) scores Sell (44.0), and the composite conceals a 66-point disagreement between its dimensions. It is strongest on competitive moat at 97 and analyst consensus at 67, and weakest on technicals at 31. A stock can carry competitive moat that high while technicals sits at 31; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 97 |
| analyst consensus | 67 |
| technicals | 31 |
StoQuant analyzes 25 signals (21 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Genelux Corporation (GNLX): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/GNLX"><img src="https://stoquant.com/badge/GNLX.svg" alt="Genelux Corporation (GNLX) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.